Literature DB >> 13672072

Isoniazid and para-aminosalicylic acid toxicity in 513 cases: a study including high doses of INH and gastrointestinal intolerance to PAS.

S J BERTE, H J DEWLETT.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1959        PMID： 13672072     DOI： 10.1378/chest.36.2.146

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  3 in total

1.  Successful oral desensitization to i.v. para-aminosalicylic acid (PAS) using encapsulated PAS dry substance.

Authors:  S M Vesenbeckh; J Becker; C Huhnt; B Karras; T T Bauer; H Mauch; H Rüssmann; N Schönfeld
Journal:  Infection       Date:  2011-08-11       Impact factor: 3.553

2.  Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.

Authors:  Lizanne de Kock; Sherwin K B Sy; Bernd Rosenkranz; Andreas H Diacon; Kim Prescott; Kenneth R Hernandez; Mingming Yu; Hartmut Derendorf; Peter R Donald
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

3.  Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS).

Authors:  Pooja V Hegde; Michael D Howe; Matthew D Zimmerman; Helena I M Boshoff; Sachin Sharma; Brianna Remache; Ziyi Jia; Yan Pan; Anthony D Baughn; Veronique Dartois; Courtney C Aldrich
Journal:  Eur J Med Chem       Date:  2022-02-19       Impact factor: 6.514
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.